Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EXPONENT INCEXPO · Entity 4154 | VP Global Offices & Innovation | April 06, 2026 | April 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EXPONENT INC
Report date April 06, 2026 · Filed April 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Incentive Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.56 · Expires 2036-04-06 | Direct | 6,008 |
Reported balance
After 2026-04-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-06 · Grant · Acquired 6,008 · Balance 6,008 F2: Not applicable. F1: The stock option becomes exercisable in four equal annual installments. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $66.56 · Expires 2036-04-06 | Direct | 14,992 |
Reported balance
After 2026-04-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-06 · Grant · Acquired 14,992 · Balance 14,992 F2: Not applicable. F1: The stock option becomes exercisable in four equal annual installments. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option becomes exercisable in four equal annual installments.
F2: Not applicable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2017 Filed Mar 17, 2017 21:40 UTC | EXPONENT INC EXPO · Entity 4154 | Exercise / conversionDividend Equivalent Rights · Derivative | 263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-17-000078 · edgardoc.xml · derivative · entry 5 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 263 shares Expires 2017-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Settlement of dividend equivalent rights in connection with RSU release on a 1:1 basis. F1 · kind: Settlement of dividend equivalent rights in connection with RSU release on a 1:1 basis. F2 · price: Not applicable. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 21:40 UTC | EXPONENT INC EXPO · Entity 4154 | GrantDividend Equivalent Rights · Derivative | 192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-17-000078 · edgardoc.xml · derivative · entry 4 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263 Underlying: Common Stock · 192 shares Expires 2017-03-15 F5 · derivative.exercise_price: The dividend equivalent rights accrued with respect to RSUs, pursuant to dividends earned in 2014 and Q1 2017. F5 · kind: The dividend equivalent rights accrued with respect to RSUs, pursuant to dividends earned in 2014 and Q1 2017. F2 · price: Not applicable. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 21:40 UTC | EXPONENT INC EXPO · Entity 4154 | Tax withholdingCommon Stock | 1,579 | $59.65 | $94,187.35 |
DisclosureSEC source: 0000851520-17-000078 · edgardoc.xml · nonDerivative · entry 3 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,367 F4 · kind: Reflects shares of common stock withheld by the Company to satify the tax withholding obligations of the Reporting Person. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 21:40 UTC | EXPONENT INC EXPO · Entity 4154 | Exercise / conversionCommon Stock | 5,064 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-17-000078 · edgardoc.xml · nonDerivative · entry 2 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Reflects the conversion of shares of vested Restricted Stock Units granted on March 15, 2013 into shares of Common Stock on a 1:1 basis. F2 · price: Not applicable. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 21:40 UTC | EXPONENT INC EXPO · Entity 4154 | Exercise / conversionCommon Stock | 263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-17-000078 · edgardoc.xml · nonDerivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Settlement of dividend equivalent rights in connection with RSU release on a 1:1 basis. F2 · price: Not applicable. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 22:35 UTC | EXPONENT INC EXPO · Entity 4154 | GrantRestricted Stock Units · Derivative | 1,704 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-17-000060 · edgardoc.xml · derivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,704 Underlying: Common Stock · 1,704 shares Expires 2021-03-10 F1 · derivative.exercise_price: 1-for-1. F2 · price: Not applicable. Read SEC document |
| December 30, 2016 Filed Feb 14, 2017 01:14 UTC | EXPONENT INC EXPO · Entity 4154 | GrantDividend Equivalent Rights · Derivative | 20 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-17-000023 · edgardoc.xml · derivative · entry 8 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20 Underlying: Common Stock · 20 shares Expires 2020-03-11 F2 · derivative.exercise_price: 1-for-1. F3 · kind: The dividend equivalent rights accrued with respect to RSUs, pursuant to dividends earned in 2016. F4 · price: Not applicable. Read SEC document |
| December 30, 2016 Filed Feb 14, 2017 01:14 UTC | EXPONENT INC EXPO · Entity 4154 | GrantDividend Equivalent Rights · Derivative | 25 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-17-000023 · edgardoc.xml · derivative · entry 7 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25 Underlying: Common Stock · 25 shares Expires 2019-03-13 F2 · derivative.exercise_price: 1-for-1. F3 · kind: The dividend equivalent rights accrued with respect to RSUs, pursuant to dividends earned in 2016. F4 · price: Not applicable. Read SEC document |
| December 30, 2016 Filed Feb 14, 2017 01:14 UTC | EXPONENT INC EXPO · Entity 4154 | GrantDividend Equivalent Rights · Derivative | 29 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-17-000023 · edgardoc.xml · derivative · entry 6 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29 Underlying: Common Stock · 29 shares Expires 2018-03-14 F2 · derivative.exercise_price: 1-for-1. F3 · kind: The dividend equivalent rights accrued with respect to RSUs, pursuant to dividends earned in 2016. F4 · price: Not applicable. Read SEC document |
| December 30, 2016 Filed Feb 14, 2017 01:14 UTC | EXPONENT INC EXPO · Entity 4154 | GrantDividend Equivalent Rights · Derivative | 71 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000851520-17-000023 · edgardoc.xml · derivative · entry 5 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71 Underlying: Common Stock · 71 shares Expires 2017-03-15 F2 · derivative.exercise_price: 1-for-1. F3 · kind: The dividend equivalent rights accrued with respect to RSUs, pursuant to dividends earned in 2016. F4 · price: Not applicable. Read SEC document |
| December 30, 2016 Filed Feb 14, 2017 01:14 UTC | EXPONENT INC EXPO · Entity 4154 | GrantCommon Stock | 28 | $57.29 | $1,603.98 |
DisclosureSEC source: 0000851520-17-000023 · edgardoc.xml · nonDerivative · entry 4 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,619 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| September 30, 2016 Filed Feb 14, 2017 01:14 UTC | EXPONENT INC EXPO · Entity 4154 | GrantCommon Stock | 29 | $48.51 | $1,406.70 |
DisclosureSEC source: 0000851520-17-000023 · edgardoc.xml · nonDerivative · entry 3 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| July 01, 2016 Filed Feb 14, 2017 01:14 UTC | EXPONENT INC EXPO · Entity 4154 | GrantCommon Stock | 29 | $55.07 | $1,597.07 |
DisclosureSEC source: 0000851520-17-000023 · edgardoc.xml · nonDerivative · entry 2 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
| April 01, 2016 Filed Feb 14, 2017 01:14 UTC | EXPONENT INC EXPO · Entity 4154 | GrantCommon Stock | 29 | $48.06 | $1,393.75 |
DisclosureSEC source: 0000851520-17-000023 · edgardoc.xml · nonDerivative · entry 1 Pye John · CIK 0001686997 · Group Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29 F1 · shares: Acquisition of stock pursuant to Exponent, Inc. Employee Stock Purchase Plan under the provisions of Section 423 of the Internal Revenue Code in a transaction exempt under SEC Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.